SCHEMBL6737838

SCHEMBL6737838

O=[N+]([O-])c1cc(Cl)ccc1-c1ccc(CCl)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 1/20 0.51
KDM1A O60341 1/20 0.44
RCOR1 Q9UKL0 1/20 0.44
MAPT P10636 7/20 0.43
ALDH1A1 P00352 6/20 0.43
HPGD P15428 6/20 0.43
HTT P42858 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPK1 P28482 4/20 0.42
TSHR P16473 1/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6872770 0.78 PDE7A (0.41) PDE7AKDM1ARCOR1MAPTALDH1A1
SCHEMBL2262163 0.77 MAPT (0.63) PDE7AKDM1ARCOR1MAPTALDH1A1
SCHEMBL2636854 0.76 ALDH1A1 (0.68) PDE7AKDM1ARCOR1MAPTALDH1A1
SCHEMBL6125034 0.76 MAPK1 (0.63) PDE7AMAPTALDH1A1HPGDTDP1
SCHEMBL6200291 0.73 PDE7A (0.50) PDE7AKDM1ARCOR1MAPTALDH1A1
SCHEMBL2138649 0.71 MAPK1 (0.57) PDE7AMAPTALDH1A1HPGDTDP1
SCHEMBL67686 0.70 ALDH1A1 (0.58) PDE7AMAPTALDH1A1HPGDTDP1
SCHEMBL31358680 0.70 KMT2A (0.58) MAPTALDH1A1HPGDHTTTDP1
SCHEMBL6367662 0.70 AAK1 (0.51) PDE7AKDM1ARCOR1MAPTALDH1A1
SCHEMBL11482739 0.68 MAPT (0.51) PDE7AMAPTALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242591-A1 Oxazolidinone derivatives as pontential antimicrobials RANBAXY LABORATORIES LIMITED (IN) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242591-A1 Oxazolidinone derivatives as pontential antimicrobials PDK4, OXA1L, PPARD PDE7A 1394/4885KDM1A 3690/4885RCOR1 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.